The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
OncoCyte Corporation(NASDAQ:OCX) 
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early stage adenocarcinoma of the lung; and ...
Website: http://www.oncocyte.com
Founded: 2009
Full Time Employees: 33
Sector: Healthcare
Industry: Biotechnology
OncoCyte Number of Twitter Followers
OncoCyte Days Payable Outstanding ttm (DPO)
OncoCyte Days Receivable Outstanding ttm (DSO)
OncoCyte Days Inventory Outstanding ttm (DIO)
OncoCyte Op Cashflow Per Share ttm
OncoCyte Free Cashflow Per Share ttm
OncoCyte Cash Per Share ttm
OncoCyte P/S ratio ttm
OncoCyte (GAAP) P/E ratio ttm
OncoCyte P/B ratio ttm
No extra charts and metrics for this ticker.